Literature DB >> 11272542

Charge effects on oxygen atom transfer.

S B Seymore1, S N Brown.   

Abstract

The rhenium(V) complex [(HCpz3)ReOCl2]+ ([1]+), the tris(pyrazolyl)methane analogue of the known tris(pyrazolyl)borate complex (HBpz3)ReOCl2 (2), has been prepared. The two complexes are strikingly similar, as are the phosphine oxide adducts [(HCpz3)ReCl2(OPPh3)]Cl ([3]Cl) and (HBpz3)ReCl2(OPPh3) (4), which have been characterized by X-ray crystallography. Comparison of the bimolecular reduction of [1]BF4 and 2 by triarylphosphines reveals a pronounced charge effect, with the cationic species being reduced by PPh3 about 1,000 times faster than its neutral analogue in CH2Cl2 at room temperature. Ligand substitution of the adducts [3]+ and 4 is dissociative, with the cationic complex dissociating phosphine oxide about 56 times more slowly than the neutral compound. The relative impact of charge on ground and transition states in atom transfer reactions is discussed.

Entities:  

Year:  2000        PMID: 11272542     DOI: 10.1021/ic990851b

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  3 in total

1.  Influence of the oxygen atom acceptor on the reaction coordinate and mechanism of oxygen atom transfer from the dioxo-Mo(VI) complex, Tp(iPr)MoO(2)(OPh), to tertiary phosphines.

Authors:  Partha Basu; Brian W Kail; Charles G Young
Journal:  Inorg Chem       Date:  2010-06-07       Impact factor: 5.165

2.  The syntheses and structures of '3+2' and '2+2+1' oxorhenium mixed-ligand complexes employing 8-hydroxy-5-nitroquinoline as the bidentate N,O donor ligand.

Authors:  Xiaoyuan Chen; Frank J Femia; John W Babich; Jon Zubieta
Journal:  Inorganica Chim Acta       Date:  2000-10-20       Impact factor: 2.545

3.  Synthesis, Characterization, DNA Binding, and Photocleavage Activity of Oxorhenium (V) Complexes with alpha-Diimine and Quinoxaline Ligands.

Authors:  Christiana A Mitsopoulou; Constantinos Dagas
Journal:  Bioinorg Chem Appl       Date:  2010-06-08       Impact factor: 7.778

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.